Keyaerts M - Search Results

1

Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging.

Keyaerts M, Remory I, Caveliers V, Breckpot K, Bos TJ, Poelaert J, Bossuyt A, Lahoutte T. Keyaerts M, et al. PLoS One. 2012;7(1):e30061. doi: 10.1371/journal.pone.0030061. Epub 2012 Jan 10. PLoS One. 2012. PMID: 22253879 Free PMC article.

2

Clinicopathological and molecular predictors of [¹⁸F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.

Llombart-Cussac A, Prat A, Pérez-García JM, Mateos J, Pascual T, Escrivà-de-Romani S, Stradella A, Ruiz-Borrego M, de Las Heras BB, Keyaerts M, Galvan P, Brasó-Maristany F, García-Mosquera JJ, Guiot T, Gion M, Sampayo-Cordero M, Di Cosimo S, Pérez-Escuredo J, de Frutos MA, Cortés J, Gebhart G. Llombart-Cussac A, et al. Among authors: keyaerts m. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2733-2743. doi: 10.1007/s00259-024-06683-0. Epub 2024 Apr 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38587643 Free PMC article. Clinical Trial.

3

Optimal [¹⁸F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.

Gebhart G, Keyaerts M, Guiot T, Flamen P, Ruiz-Borrego M, Stradella A, Bermejo B, Escriva-de-Romani S, Calvo Martínez L, Ribelles N, Fernandez-Abad M, Albacar C, Colleoni M, Garrigos L, Atienza de Frutos M, Dalenc F, Prat A, Marmé F, Schmid P, Kerrou K, Braga S, Gener P, Sampayo-Cordero M, Cortés J, Pérez-García JM, Llombart-Cussac A. Gebhart G, et al. Among authors: keyaerts m. J Nucl Med. 2024 May 1;65(5):708-713. doi: 10.2967/jnumed.123.266384. J Nucl Med. 2024. PMID: 38575192

4

123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.

Keyaerts M, Lahoutte T, Neyns B, Caveliers V, Vanhove C, Everaert H, Kersemans K, Franken PR, Mertens J, Bossuyt A. Keyaerts M, et al. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):994-1002. doi: 10.1007/s00259-006-0303-3. Epub 2007 Jan 20. Eur J Nucl Med Mol Imaging. 2007. PMID: 17237962

5

Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.

Bauwens M, Keyaerts M, Lahoutte T, Kersemans K, Caveliers V, Bossuyt A, Mertens J. Bauwens M, et al. Among authors: keyaerts m. Nucl Med Commun. 2007 Oct;28(10):823-8. doi: 10.1097/MNM.0b013e3282e7d731. Nucl Med Commun. 2007. PMID: 17728613

6

Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.

Keyaerts M, Verschueren J, Bos TJ, Tchouate-Gainkam LO, Peleman C, Breckpot K, Vanhove C, Caveliers V, Bossuyt A, Lahoutte T. Keyaerts M, et al. Eur J Nucl Med Mol Imaging. 2008 May;35(5):999-1007. doi: 10.1007/s00259-007-0664-2. Epub 2008 Jan 4. Eur J Nucl Med Mol Imaging. 2008. PMID: 18180921

7

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Huang L, Gainkam LO, Caveliers V, Vanhove C, Keyaerts M, De Baetselier P, Bossuyt A, Revets H, Lahoutte T. Huang L, et al. Among authors: keyaerts m. Mol Imaging Biol. 2008 May-Jun;10(3):167-75. doi: 10.1007/s11307-008-0133-8. Epub 2008 Feb 23. Mol Imaging Biol. 2008. PMID: 18297364

8

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T. Gainkam LO, et al. Among authors: keyaerts m. J Nucl Med. 2008 May;49(5):788-95. doi: 10.2967/jnumed.107.048538. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413403 Free article.

9

Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes.

Goethals LR, Weytjens CD, De Geeter F, Droogmans S, Caveliers V, Keyaerts M, Vanhove C, Van Camp G, Bossuyt A, Lahoutte T. Goethals LR, et al. Among authors: keyaerts m. Contrast Media Mol Imaging. 2009 Jul-Aug;4(4):174-82. doi: 10.1002/cmmi.278. Contrast Media Mol Imaging. 2009. PMID: 19672853 Free article.

10

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

Breckpot K, Escors D, Arce F, Lopes L, Karwacz K, Van Lint S, Keyaerts M, Collins M. Breckpot K, et al. Among authors: keyaerts m. J Virol. 2010 Jun;84(11):5627-36. doi: 10.1128/JVI.00014-10. Epub 2010 Mar 17. J Virol. 2010. PMID: 20237085 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters